Zu Ye
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Immunology top 10%
- interferon and immune responses
Papers in
- Oncology 10
- PARP inhibition in cancer therapy 7
-
- DNA Repair Mechanisms 8
- CRISPR and Genetic Engineering 5
- Protein Tyrosine Phosphatases 5
- Protein Kinase Regulation and GTPase Signaling 3
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- John A. Tainer (6 shared papers)Albino Bacolla (4 shared papers)Zamal Ahmed (4 shared papers)Yin Pu Shi (10 shared papers)Qi Zeng (3 shared papers)Shengfeng Xu (6 shared papers)Jing Ji (4 shared papers)SANKAR P. MITRA (2 shared papers)
- Journals
- Free Radical Biology and Medicine (2 papers)Advanced Science (2 papers)World Journal of Gastroenterology (2 papers)Biomolecules (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Zu Ye
30 papers receiving 1.3k citations
Zu Ye's Hit Papers
Peers
Comparison fields: 5 of 84
- Nephrology 121
- Immunology 299
- Molecular Biology 890
- Oncology 271
- Cancer Research 103
Countries citing papers authored by Zu Ye
This map shows the geographic impact of Zu Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zu Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zu Ye more than expected).
Fields of papers citing papers by Zu Ye
This network shows the impact of papers produced by Zu Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zu Ye. The network helps show where Zu Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Zu Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis Hit paper breakdown → | 2020 | 762 |
| 2 | 2019 | 100 | |
| 3 | 2019 | 43 | |
| 4 | 2020 | 42 | |
| 5 | 2021 | 30 | |
| 6 | 2020 | 29 | |
| 7 | 2019 | 29 | |
| 8 | 2024 | 26 | |
| 9 | 2024 | 26 | |
| 10 | 2015 | 25 | |
| 11 | 2021 | 23 | |
| 12 | 2024 | 21 | |
| 13 | 2021 | 17 | |
| 14 | 2024 | 17 | |
| 15 | 2021 | 13 | |
| 16 | 2023 | 10 | |
| 17 | 2025 | 9 | |
| 18 | 2024 | 8 | |
| 19 | 2024 | 7 | |
| 20 | 2024 | 6 |
About Zu Ye
Zu Ye is a scholar working on Oncology, Molecular Biology, Cell Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (8 papers), PARP inhibition in cancer therapy (7 papers), CRISPR and Genetic Engineering (5 papers), Protein Tyrosine Phosphatases (5 papers), Microtubule and mitosis dynamics (3 papers), Gastric Cancer Management and Outcomes (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Nephrology (121 citations), Immunology (299 citations), Molecular Biology (890 citations), Oncology (271 citations) and Cancer Research (103 citations). Zu Ye has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include John A. Tainer, Albino Bacolla, Zamal Ahmed, Yin Pu Shi, Qi Zeng, Shengfeng Xu, Jing Ji, SANKAR P. MITRA, Dingyi Wang and Muralidhar L. Hegde. Their work appears in journals such as Free Radical Biology and Medicine, Advanced Science, World Journal of Gastroenterology, Biomolecules and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.